FDA approved first vaccine to prevent disease caused by chikungunya virus
On Nov. 9, 2023, the U.S. Food and Drug Administration (FDA) approved Valneva’s Ixchiq, the first chikungunya vaccine….
Novavax’s updated COVID-19 vaccine approved in the EU
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
Bavarian Nordic’s Mpox vaccine received recommendation from U.S. CDC Advisory Committee for routine use in adults at risk
On Oct. 25, 2023, Bavarian Nordic announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory…
U.S. CDC reported high rates of child flu hospitalizations recorded in 2022-2023 season
On Oct. 20, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that among children and…
FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) had granted full approval for Novavax’s…
Two fatal human influenza A/H5N1 (Bird Flu) virus infections reported in Cambodia
On Oct. 12, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that two fatal human…
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
New funding ensured 370 million children receive polio vaccinations in low-income countries
On Oct. 11, 2023, the European Commission, the European Investment Bank and the Bill & Melinda Gates Foundation…
GSK and Zhifei announced exclusive strategic vaccine partnership in China with $3 billion
On Oct. 9, 2023, GlaxoSmithKline announced that it had reached an exclusive agreement with Chongqing Zhifei Biological Products…
FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant
On Oct. 3, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of…
Biotechnology | CDC | COVID-19 | FDA | Infectious Disease | Vaccine
Novavax 2023-2024 COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
Vir Biotechnology awarded BARDA funding to support development of antibody platform technologies for global infectious disease threats
On Oct. 3, 2023, Vir Biotechnology announced that the Biomedical Advanced Research and Development Authority (BARDA), part of…
Agriculture | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine
France kicked off world first bird flu vaccination despite trade backlash
On Oct. 2, 2023, France began vaccinating ducks against bird flu to try and stem the virus that…
COVID-19 | CRISPR | Therapeutics | Vaccine
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
WHO recommended R21/Matrix-M vaccine for malaria prevention
On Oct. 2, 2023, the World Health Organization (WHO) announced it had recommended a new vaccine, R21/Matrix-M, developed…
Agriculture | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine
USDA Protected U.S. Poultry with Restrictions on Poultry Products from France and the European Union
On Sept. 29, 2023, The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) announced it…
Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
West Nile virus reported in humans and horses from four counties in Washington state
On Sept. 25, 2023, the Washington State Department of Health confirmed the presence of West Nile virus in…
Biotechnology | HIV | NIH | Non-Profit Research | Therapeutics | Vaccine
Clinical trial of HIV vaccine began in United States and South Africa
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…
National Institutes of Health clinical trial of universal flu vaccine candidate began
On Sept. 15, 2023, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) announced they had…
Moderna received U.S. FDA approval for updated COVID-19 vaccine
On Sept. 11, 2023, Moderna announced the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
Biotechnology | COVID-19 | FDA | Vaccine
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirmed its updated COVID-19…
COVID-19 | FDA | Infectious Disease | Vaccine
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
CDC’s ACIP announced vaccines recommendation for 2023-24 seasonal influenza
On Aug. 25. 2023, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in infants through active immunization of pregnant Individuals
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…